Prevalence of antiplatelet therapy in patients with diabetes
<p>Abstract</p> <p>Objective</p> <p>To determine the prevalence of, and patient characteristics associated with, antiplatelet therapy in a cohort of primary care patients with Type 1 or Type2 diabetes.</p> <p>Methods</p> <p>Subjects participating...
Main Authors: | Littenberg Benjamin, Miller Shaun R, MacLean Charles D |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-12-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/4/1/18 |
Similar Items
-
Intra-cluster correlation coefficients in adults with diabetes in primary care practices: the Vermont Diabetes Information System field survey
by: MacLean Charles D, et al.
Published: (2006-05-01) -
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
by: MacLean Charles D, et al.
Published: (2007-06-01) -
Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information system
by: MacLean Charles D, et al.
Published: (2008-12-01) -
Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
by: Kennedy Amanda G, et al.
Published: (2006-08-01) -
The use of adherence aids by adults with diabetes: A cross-sectional survey
by: MacLean Charles D, et al.
Published: (2006-01-01)